Global Cell-Free Fetal DNA Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Cell-Free Fetal DNA Testing Market Research Report 2024
Cell-free DNA screening is a test that can determine if a woman has a higher chance of having a fetus with Down syndrome (trisomy 21), trisomy 18, trisomy 13 or an abnormality in the sex chromosomes (X and Y chromosomes). With this test, a sample of the woman's blood is taken after 10 weeks of pregnancy.
According to MRAResearch’s new survey, global Cell-Free Fetal DNA Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Key companies engaged in the Cell-Free Fetal DNA Testing industry include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cell-Free Fetal DNA Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cell-Free Fetal DNA Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cell-Free Fetal DNA Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Segment by Type
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others
Hospital
Clinic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cell-Free Fetal DNA Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Cell-Free Fetal DNA Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Key companies engaged in the Cell-Free Fetal DNA Testing industry include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cell-Free Fetal DNA Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cell-Free Fetal DNA Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cell-Free Fetal DNA Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Segment by Type
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others
Segment by Application
Hospital
Clinic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cell-Free Fetal DNA Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source